Zonegran
NDC 59212-681, Zonisamide, capsule, from Advanz Pharma (US) Corp..
- Product NDC
- 59212-681
- Status
- Listed
- Labeler
- Advanz Pharma (US) Corp.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020789
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59212-681 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZONISAMIDE25 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; P-Glycoprotein Inhibitors [MoA]; Sulfonamides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59212-681-10 | 59212068110 | 100 CAPSULE in 1 BOTTLE (59212-681-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d12de43e-3ac3-4335-bc85-70d7366a91eb
Use it
Look up 59212-681 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59212-681 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59212-681. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.